Log in

OCPH October Pharma Co. EGX · Egypt

October Pharma Co. (OCPH) news

October Pharma Co. is a public biotech or pharmaceutical company listed on EGX under the ticker OCPH, recorded under Egypt. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Questions about October Pharma Co.

What is the ticker symbol of October Pharma Co.?

October Pharma Co. trades under the ticker OCPH on EGX.

Where is October Pharma Co. listed?

October Pharma Co. is listed on EGX.

Which country or territory is October Pharma Co. listed under?

Our directory records October Pharma Co. under Egypt.

What does October Pharma Co. do?

Our directory classifies October Pharma Co. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of October Pharma Co.?

The ISIN recorded for October Pharma Co. is EGS380R1C018.

Does aibio.space cover October Pharma Co.?

aibio.space lists October Pharma Co. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to October Pharma Co.?

Companies in our directory listed in the same country and business area as October Pharma Co.: Arab Pharmaceuticals, Alexandria Company for Pharmaceuticals and Chemical Industries, Sabaa International Company for Pharmaceutial and Chemical Industry, Minapharm Pharmaceuticals, Memphis Pharmaceutical & Chemical Industries, Macro Group Pharmaceutical S.A.E..

Investor discussion: October Pharma Co.

Members talk about October Pharma Co. (OCPH). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open EGX:OCPH on TradingView.

Listing details

October Pharma Co. is a public biotech or pharmaceutical company listed on EGX under the ticker OCPH, recorded under Egypt. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
October Pharma Co.
Ticker
OCPH
Listing
EGX
Country or territory
Egypt
Business scope
Pharmaceuticals: Major
ISIN
EGS380R1C018
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.